celecoxib has been researched along with Temporomandibular Joint Disorders in 4 studies
Temporomandibular Joint Disorders: A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed, pp577-600)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib and naproxen were well tolerated, with similar number of reported adverse effects." | 2.71 | Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen. ( Dionne, RA; Ta, LE, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yim, CR | 1 |
| Uhrich, RM | 1 |
| Perez, L | 1 |
| Su, SC | 1 |
| Tanimoto, K | 1 |
| Tanne, Y | 1 |
| Kunimatsu, R | 1 |
| Hirose, N | 1 |
| Mitsuyoshi, T | 1 |
| Okamoto, Y | 1 |
| Tanne, K | 1 |
| Kawashima, M | 1 |
| Ogura, N | 1 |
| Akutsu, M | 1 |
| Ito, K | 1 |
| Kondoh, T | 1 |
| Ta, LE | 1 |
| Dionne, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Preliminary Findings of the Efficacy of Botulinum Toxin in Temporomandibular Disorders: A Randomized Clinical Trial[NCT05651256] | Phase 2/Phase 3 | 20 participants (Actual) | Interventional | 2021-03-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for celecoxib and Temporomandibular Joint Disorders
| Article | Year |
|---|---|
Treatment of Temporomandibular Joint Heterotopic Ossification: A Novel Protocol With Multimodal Therapy Based on Literature Review and Presentation of a Unique Case Report.
Topics: Celecoxib; Combined Modality Therapy; Etidronic Acid; Humans; Joint Prosthesis; Ossification, Hetero | 2022 |
1 trial available for celecoxib and Temporomandibular Joint Disorders
| Article | Year |
|---|---|
Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen.
Topics: Adult; Celecoxib; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inh | 2004 |
2 other studies available for celecoxib and Temporomandibular Joint Disorders
| Article | Year |
|---|---|
Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Celecoxib; Cells, Cultured; Cho | 2014 |
The anti-inflammatory effect of cyclooxygenase inhibitors in fibroblast-like synoviocytes from the human temporomandibular joint results from the suppression of PGE2 production.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cell Culture Techniques; Cell | 2013 |